Cardiac rehabilitation for patients with obesity: lessons learned from the OPTICARE XL trial
- PMID: 37982980
- PMCID: PMC10781911
- DOI: 10.1007/s12471-023-01832-w
Cardiac rehabilitation for patients with obesity: lessons learned from the OPTICARE XL trial
Abstract
Obesity is a known and commonly encountered risk factor for the development of cardiac diseases. Patients with cardiac diseases who also have obesity do not benefit optimally from standard cardiac rehabilitation (CR) programs. Exercises performed during CR are not the best fit for patients with obesity and counselling sessions often do not address their specific needs. OPTICARE XL is the first large multicentre randomised controlled trial to investigate the added value of a dedicated one-year CR program specifically designed for patients with obesity and integrated in daily practice. The short-term effects on body weight and physical activity were promising and patients with obesity experienced the program as highly desirable. However, the OPTICARE XL CR program did not show long-term added value compared with standard CR on health-related quality of life, psychosocial well-being, body weight, physical activity and physical fitness, nor on costs. The current article offers an overview of the background of this trial and discusses the most important results of the OPTICARE XL trial and the reasons behind the unanticipated long-term outcomes. Furthermore, it offers recommendations for future research and how to redesign the OPTICARE XL CR program to expand the short-term results.
Keywords: Atrial fibrillation; Cardiac rehabilitation; Cardiovascular disease; Lifestyle; Obesity.
© 2023. The Author(s).
Conflict of interest statement
I. den Uijl, M. Sunamura, R.M.W. Brouwers, H.J. Stam, E. Boersma, R.J.G. van den Berg-Emons and N. ter Hoeve declare that they have no competing interests.
References
-
- Kotseva K, De Backer G, De Bacquer D, et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European society of cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol. 2019;26:824–835. doi: 10.1177/2047487318825350. - DOI - PubMed
-
- Piepoli MF, Hoes AW, Agewall S, et al. European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur Heart J. 2016;2016:2315. doi: 10.1093/eurheartj/ehw106. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources